Connection

Kim Payne to Ikaros Transcription Factor

Back to Details
This is a "connection" page, showing publications Kim Payne has written about Ikaros Transcription Factor.
Kim Payne
Connection Strength
2.434
Ikaros Transcription Factor
  1. Ikaros and tumor suppression in acute lymphoblastic leukemia. Crit Rev Oncog. 2011; 16(1-2):3-12.
    View in: PubMed
    Score: 0.349
  2. Tumor suppression in T cell leukemia--the role of Ikaros. Leuk Res. 2010 Apr; 34(4):416-7.
    View in: PubMed
    Score: 0.322
  3. Increased Incidence of IKZF1 deletions and IGH-CRLF2 translocations in B-ALL of Hispanic/Latino children-a novel health disparity. Leukemia. 2021 08; 35(8):2399-2402.
    View in: PubMed
    Score: 0.176
  4. IKAROS and CK2 regulate expression of BCL-XL and chemosensitivity in high-risk B-cell acute lymphoblastic leukemia. Blood. 2020 09 24; 136(13):1520-1534.
    View in: PubMed
    Score: 0.171
  5. Ikaros tumor suppressor function includes induction of active enhancers and super-enhancers along with pioneering activity. Leukemia. 2019 11; 33(11):2720-2731.
    View in: PubMed
    Score: 0.156
  6. Casein Kinase II (CK2), Glycogen Synthase Kinase-3 (GSK-3) and Ikaros mediated regulation of leukemia. Adv Biol Regul. 2017 08; 65:16-25.
    View in: PubMed
    Score: 0.136
  7. High CRLF2 expression associates with IKZF1 dysfunction in adult acute lymphoblastic leukemia without CRLF2 rearrangement. Oncotarget. 2016 Aug 02; 7(31):49722-49732.
    View in: PubMed
    Score: 0.128
  8. Co-existence of IL7R high and SH2B3 low expression distinguishes a novel high-risk acute lymphoblastic leukemia with Ikaros dysfunction. Oncotarget. 2016 Jul 19; 7(29):46014-46027.
    View in: PubMed
    Score: 0.128
  9. Transcriptional Regulation of JARID1B/KDM5B Histone Demethylase by Ikaros, Histone Deacetylase 1 (HDAC1), and Casein Kinase 2 (CK2) in B-cell Acute Lymphoblastic Leukemia. J Biol Chem. 2016 Feb 19; 291(8):4004-18.
    View in: PubMed
    Score: 0.123
  10. Targeting casein kinase II restores Ikaros tumor suppressor activity and demonstrates therapeutic efficacy in high-risk leukemia. Blood. 2015 Oct 08; 126(15):1813-22.
    View in: PubMed
    Score: 0.120
  11. Protein phosphatase 1 (PP1) and Casein Kinase II (CK2) regulate Ikaros-mediated repression of TdT in thymocytes and T-cell leukemia. Pediatr Blood Cancer. 2014 Dec; 61(12):2230-5.
    View in: PubMed
    Score: 0.113
  12. Cell cycle-specific function of Ikaros in human leukemia. Pediatr Blood Cancer. 2012 Jul 15; 59(1):69-76.
    View in: PubMed
    Score: 0.093
  13. Ikaros, CK2 kinase, and the road to leukemia. Mol Cell Biochem. 2011 Oct; 356(1-2):201-7.
    View in: PubMed
    Score: 0.090
  14. Ikaros stability and pericentromeric localization are regulated by protein phosphatase 1. J Biol Chem. 2009 May 15; 284(20):13869-13880.
    View in: PubMed
    Score: 0.077
  15. Recruitment of ikaros to pericentromeric heterochromatin is regulated by phosphorylation. J Biol Chem. 2008 Mar 28; 283(13):8291-300.
    View in: PubMed
    Score: 0.071
  16. Human Ikaros function in activated T cells is regulated by coordinated expression of its largest isoforms. J Biol Chem. 2007 Jan 26; 282(4):2538-47.
    View in: PubMed
    Score: 0.066
  17. Ikaros isoform x is selectively expressed in myeloid differentiation. J Immunol. 2003 Mar 15; 170(6):3091-8.
    View in: PubMed
    Score: 0.051
  18. The Current Genomic and Molecular Landscape of Philadelphia-like Acute Lymphoblastic Leukemia. Int J Mol Sci. 2020 Mar 22; 21(6).
    View in: PubMed
    Score: 0.041
  19. Radical reversal of vasoactive intestinal peptide (VIP) receptors during early lymphopoiesis. Peptides. 2011 Oct; 32(10):2058-66.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.